185 related articles for article (PubMed ID: 36625844)
1. The effects of cannabidiol on subjective states, cognition, and psychomotor function in healthy adults: A randomized clinical trial.
Rudisill TM; Innes KK; Wen S; Haggerty T; Smith GS
Fundam Clin Pharmacol; 2023 Jun; 37(3):663-672. PubMed ID: 36625844
[TBL] [Abstract][Full Text] [Related]
2. Abuse potential assessment of cannabidiol (CBD) in recreational polydrug users: A randomized, double-blind, controlled trial.
Schoedel KA; Szeto I; Setnik B; Sellers EM; Levy-Cooperman N; Mills C; Etges T; Sommerville K
Epilepsy Behav; 2018 Nov; 88():162-171. PubMed ID: 30286443
[TBL] [Abstract][Full Text] [Related]
3. Separate and combined effects of alcohol and cannabis on mood, subjective experience, cognition and psychomotor performance: A randomized trial.
Wickens CM; Wright M; Mann RE; Brands B; Di Ciano P; Stoduto G; Fares A; Matheson J; George TP; Rehm J; Shuper PA; Sproule B; Samohkvalov A; Huestis MA; Le Foll B
Prog Neuropsychopharmacol Biol Psychiatry; 2022 Aug; 118():110570. PubMed ID: 35551928
[TBL] [Abstract][Full Text] [Related]
4. Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients.
Bergamaschi MM; Queiroz RH; Chagas MH; de Oliveira DC; De Martinis BS; Kapczinski F; Quevedo J; Roesler R; Schröder N; Nardi AE; Martín-Santos R; Hallak JE; Zuardi AW; Crippa JA
Neuropsychopharmacology; 2011 May; 36(6):1219-26. PubMed ID: 21307846
[TBL] [Abstract][Full Text] [Related]
5. A randomised, placebo-controlled, double blind, crossover trial on the effect of a 20:1 cannabidiol: Δ9-tetrahydrocannabinol medical cannabis product on neurocognition, attention, and mood.
Manning B; Hayley AC; Catchlove S; Stough C; Downey LA
Eur Neuropsychopharmacol; 2024 May; 82():35-43. PubMed ID: 38490083
[TBL] [Abstract][Full Text] [Related]
6. Alertness and psychomotor performance effects of the histamine-3 inverse agonist MK-0249 in obstructive sleep apnea patients on continuous positive airway pressure therapy with excessive daytime sleepiness: a randomized adaptive crossover study.
Herring WJ; Liu K; Hutzelmann J; Snavely D; Snyder E; Ceesay P; Lines C; Michelson D; Roth T
Sleep Med; 2013 Oct; 14(10):955-63. PubMed ID: 23920422
[TBL] [Abstract][Full Text] [Related]
7. Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition.
Arkell TR; Lintzeris N; Kevin RC; Ramaekers JG; Vandrey R; Irwin C; Haber PS; McGregor IS
Psychopharmacology (Berl); 2019 Sep; 236(9):2713-2724. PubMed ID: 31044290
[TBL] [Abstract][Full Text] [Related]
8. Effect of Cannabidiol and Δ9-Tetrahydrocannabinol on Driving Performance: A Randomized Clinical Trial.
Arkell TR; Vinckenbosch F; Kevin RC; Theunissen EL; McGregor IS; Ramaekers JG
JAMA; 2020 Dec; 324(21):2177-2186. PubMed ID: 33258890
[TBL] [Abstract][Full Text] [Related]
9. The Effects of Cannabidiol on the Driving Performance of Healthy Adults: A Pilot RCT.
Rudisill TM; Innes KK; Wen S; Haggerty T; Smith GS
AJPM Focus; 2023 Mar; 2(1):. PubMed ID: 36844251
[TBL] [Abstract][Full Text] [Related]
10. Effects of desloratadine and alcohol coadministration on psychomotor performance.
Scharf M; Berkowitz D
Curr Med Res Opin; 2007 Feb; 23(2):313-21. PubMed ID: 17288686
[TBL] [Abstract][Full Text] [Related]
11. The effect of cannabidiol on simulated car driving performance: A randomised, double-blind, placebo-controlled, crossover, dose-ranging clinical trial protocol.
McCartney D; Benson MJ; Suraev AS; Irwin C; Arkell TR; Grunstein RR; Hoyos CM; McGregor IS
Hum Psychopharmacol; 2020 Sep; 35(5):e2749. PubMed ID: 32729120
[TBL] [Abstract][Full Text] [Related]
12. Effect of four-week cannabidiol treatment on cognitive function: secondary outcomes from a randomised clinical trial for the treatment of cannabis use disorder.
Lees R; Hines LA; Hindocha C; Baio G; Shaban NDC; Stothart G; Mofeez A; Morgan CJA; Curran HV; Freeman TP
Psychopharmacology (Berl); 2023 Feb; 240(2):337-346. PubMed ID: 36598543
[TBL] [Abstract][Full Text] [Related]
13. Psychomotor performance in healthy young adult volunteers receiving lormetazepam and placebo: a single-dose, randomized, double-blind, crossover trial.
Fabbrini M; Frittelli C; Bonanni E; Maestri M; Manca ML; Iudice A
Clin Ther; 2005 Jan; 27(1):78-83. PubMed ID: 15763608
[TBL] [Abstract][Full Text] [Related]
14. Characterization of daytime sleepiness and psychomotor performance following H1 receptor antagonists.
Witek TJ; Canestrari DA; Miller RD; Yang JY; Riker DK
Ann Allergy Asthma Immunol; 1995 May; 74(5):419-26. PubMed ID: 7749974
[TBL] [Abstract][Full Text] [Related]
15. A double-blind, placebo-controlled, randomized trial of Ginkgo biloba extract EGb 761 in a sample of cognitively intact older adults: neuropsychological findings.
Mix JA; Crews WD
Hum Psychopharmacol; 2002 Aug; 17(6):267-77. PubMed ID: 12404671
[TBL] [Abstract][Full Text] [Related]
16. Effect of Delta-9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adults.
Nicholson AN; Turner C; Stone BM; Robson PJ
J Clin Psychopharmacol; 2004 Jun; 24(3):305-13. PubMed ID: 15118485
[TBL] [Abstract][Full Text] [Related]
17. The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial.
Boggs DL; Surti T; Gupta A; Gupta S; Niciu M; Pittman B; Schnakenberg Martin AM; Thurnauer H; Davies A; D'Souza DC; Ranganathan M
Psychopharmacology (Berl); 2018 Jul; 235(7):1923-1932. PubMed ID: 29619533
[TBL] [Abstract][Full Text] [Related]
18. Psychomotor vigilance performance predicted by Epworth Sleepiness Scale scores in an operational setting with the United States Navy.
Shattuck NL; Matsangas P
J Sleep Res; 2015 Apr; 24(2):174-80. PubMed ID: 25273376
[TBL] [Abstract][Full Text] [Related]
19. A single-center, randomized, double-blind, placebo-controlled, crossover investigation of the effects of fexofenadine hydrochloride 180 mg alone and with alcohol, with hydroxyzine hydrochloride 50 mg as a positive internal control, on aspects of cognitive and psychomotor function related to driving a car.
Ridout F; Shamsi Z; Meadows R; Johnson S; Hindmarch I
Clin Ther; 2003 May; 25(5):1518-38. PubMed ID: 12867226
[TBL] [Abstract][Full Text] [Related]
20. Dose-Response of Paraxanthine on Cognitive Function: A Double Blind, Placebo Controlled, Crossover Trial.
Xing D; Yoo C; Gonzalez D; Jenkins V; Nottingham K; Dickerson B; Leonard M; Ko J; Faries M; Kephart W; Purpura M; Jäger R; Wells SD; Sowinski R; Rasmussen CJ; Kreider RB
Nutrients; 2021 Dec; 13(12):. PubMed ID: 34960030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
